Summit X, LLC Edwards Lifesciences Corp Transaction History

Summit X, LLC

$423 Million
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$81.41 - $94.33 $6,757 - $7,829	83 Added 1.15%	7,328 $691,000
Q1 2023 May 10, 2023	SELL	$74.26 - $84.51 $23,391 - $26,620	-315 Reduced 4.17%	7,245 $599,000
Q4 2022 Feb 02, 2023	BUY	$68.3 - $87.44 $6,147 - $7,869	90 Added 1.2%	7,560 $564,000
Q3 2022 Nov 01, 2022	SELL	$82.37 - $107.29 $7,413 - $9,656	-90 Reduced 1.19%	7,470 $619,000
Q2 2022 Aug 12, 2022	SELL	$86.5 - $128.27 $12,975 - $19,240	-150 Reduced 1.95%	7,560 $721,000
Q1 2022 May 05, 2022	SELL	$101.96 - $128.34 $329,840 - $415,179	-3,235 Reduced 29.56%	7,710 $905,000
Q4 2021 Jan 19, 2022	BUY	$106.37 - $130.68 $7,445 - $9,147	70 Added 0.64%	10,945 $1.42 Million
Q3 2021 Oct 19, 2021	SELL	$102.91 - $122.75 $1,543 - $1,841	-15 Reduced 0.14%	10,875 $1.23 Million
Q2 2021 Jul 16, 2021	SELL	$83.84 - $104.76 $17,187 - $21,475	-205 Reduced 1.85%	10,890 $1.13 Million
Q1 2021 May 10, 2021	SELL	$78.68 - $90.67 $23,604 - $27,201	-300 Reduced 2.63%	11,095 $928,000
Q4 2020 Jan 29, 2021	SELL	$71.69 - $91.23 $22,223 - $28,281	-310 Reduced 2.65%	11,395 $1.04 Million
Q3 2020 Nov 12, 2020	BUY	$67.19 - $87.44 $228,110 - $296,858	3,395 Added 40.85%	11,705 $3.59 Million
Q2 2020 Aug 13, 2020	BUY	$57.54 - $76.95 $322,799 - $431,689	5,610 Added 207.78%	8,310 $574,000
Q1 2020 May 13, 2020	SELL	$52.41 - $81.0 $8,647 - $13,365	-165 Reduced 5.76%	2,700 $513,000
Q4 2019 Jan 23, 2020	SELL	$71.7 - $82.09 $51,982 - $59,515	-725 Reduced 20.19%	2,865 $665,000
Q3 2019 Oct 15, 2019	SELL	$61.55 - $75.43 $615 - $754	-10 Reduced 0.28%	3,590 $789,000
Q2 2019 Aug 13, 2019	BUY	$55.74 - $64.41 $557 - $644	10 Added 0.28%	3,600 $662,000
Q1 2019 May 13, 2019	BUY	$47.89 - $64.05 $7,901 - $10,568	165 Added 4.82%	3,590 $690,000
Q4 2018 Feb 13, 2019	BUY	$46.41 - $56.94 $1,392 - $1,708	30 Added 0.88%	3,425 $525,000
Q3 2018 Nov 01, 2018	BUY	$45.7 - $58.03 $1,371 - $1,740	30 Added 0.89%	3,395 $592,000
Q2 2018 Sep 24, 2018	SELL	$42.45 - $51.3 $117,459 - $141,947	-2,767 Reduced 45.12%	3,365 $488,000
Q2 2018 Aug 13, 2018	BUY	$42.45 - $51.3 $107,525 - $129,942	2,533 Added 70.38%	6,132 $488,000
Q1 2018 May 23, 2018	BUY	$37.19 - $47.45 $2,380 - $3,036	64 Added 1.81%	3,599 $506,000
Q4 2017 Jan 23, 2018	BUY	$33.79 - $39.39 $1,689 - $1,969	50 Added 1.43%	3,535 $405,000
Q3 2017 Oct 17, 2017	BUY	$36.29 - $38.83 $725 - $776	20 Added 0.58%	3,485 $377,000
Q2 2017 Aug 14, 2017	BUY	N/A	3,465	3,465 $411,000

Others Institutions Holding EW

# of Institutions

1,351

Shares Held

455M

Call Options Held

9.76M

Put Options Held

3.92M

Vanguard Group Inc Valley Forge, PA

62.6M
Shares

$4.24 Billion
0.08% of portfolio
Black Rock Inc. New York, NY

51M
Shares

$3.45 Billion
0.11% of portfolio
Wellington Management Group LLP Boston, MA

31.5M
Shares

$2.14 Billion
0.37% of portfolio
State Street Corp Boston, MA

26.3M
Shares

$1.78 Billion
0.07% of portfolio
Geode Capital Management, LLC Boston, MA

13.5M
Shares

$916 Million
0.07% of portfolio

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit X, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit X, LLC with notifications on news.

Account